Generation of two induced pluripotent stem cell lines from Charcot-Marie-Tooth type 1B patients harboring autosomal dominant mutations in myelin protein zero gene
Open Access
- 15 February 2025
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 84, 103684
Abstract
No abstract availableKeywords
Funding Information
- Nationwide Children's Hospital
This publication has 12 references indexed in Scilit:
- A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanismHuman Molecular Genetics, 2022
- Loss of function MPZ mutation causes milder CMT1B neuropathyJournal of the Peripheral Nervous System, 2021
- Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1BAnnals of Clinical and Translational Neurology, 2018
- Genotype–phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in theMPZgeneBrain, 2015
- Schwann Cell MyelinationCold Spring Harbor Perspectives in Biology, 2015
- Gain of glycosylation: A new pathomechanism of myelin protein zero mutationsAnnals of Neurology, 2011
- Charcot‐marie‐tooth disease subtypes and genetic testing strategiesAnnals of Neurology, 2011
- Peripheral neuropathies caused by mutations in the myelin protein zeroJournal of the Neurological Sciences, 2006
- Phenotypic clustering in MPZ mutationsBrain, 2004
- Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative StudyEuropean Journal of Human Genetics, 1996